Alkermes has been granted a patent for compounds to treat narcolepsy or cataplexy. The invention includes related pharmaceutical compositions and methods. GlobalData’s report on Alkermes gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Alkermes, was a key innovation area identified from patents. Alkermes's grant share as of May 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US12006330B2) discloses a compound of Formula I or a pharmaceutically acceptable salt thereof, along with a pharmaceutical composition containing this compound and a carrier. The patent also covers methods for treating narcolepsy and cataplexy by administering the compound or composition to subjects in need of treatment.
The compound of claim 1 in the patent is characterized by specific structural features, including variations in the number of certain elements within the molecule, such as n being either 1 or 2. Additionally, the compound includes different configurations for ring A, T, W, and V, providing a range of options for potential therapeutic applications. The patent further extends to pharmaceutical compositions containing the compound or its salt, offering a promising avenue for treating narcolepsy and cataplexy, two conditions that can significantly impact individuals' quality of life. Overall, the patent highlights the innovative potential of the disclosed compound and its pharmaceutical compositions in addressing these neurological disorders.
To know more about GlobalData’s detailed insights on Alkermes, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
